Latest & greatest articles for clobetasol

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on clobetasol or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on clobetasol and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for clobetasol

1. Clobetasol

Clobetasol Top results for clobetasol - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 (...) or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for clobetasol The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence

2018 Trip Latest and Greatest

2. Topical Tacrolimus is equally effective in treating patients with Oral Lichen Planus (OLP) as compared to Topical clobetasol

Topical Tacrolimus is equally effective in treating patients with Oral Lichen Planus (OLP) as compared to Topical clobetasol UTCAT2490, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Topical Tacrolimus is Equally Effective in Treating Patients with Oral Lichen Planus (OLP) as Compared to Topical Clobetasol Clinical Question Can topical tacrolimus be used as an alternate to topical clobetasol for treatment of OLP (...) ? Clinical Bottom Line In patients with OLP, topical treatment with clobetasol and tacrolimus are equally effective in reducing symptoms. However, some studies suggest that topical tacrolimus may have higher efficacy. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Sonthalia/2012 n = 40 RCT Key results 40 patients were enrolled with histologically proven diagnosis of OLP. The patients were randomly divided

2013 UTHSCSA Dental School CAT Library

3. Relative efficacy and interchangeability of various clobetasol propionate vehicles in the management of steroid-responsive dermatoses

Relative efficacy and interchangeability of various clobetasol propionate vehicles in the management of steroid-responsive dermatoses Relative efficacy and interchangeability of various clobetasol propionate vehicles in the management of steroid-responsive dermatoses Relative efficacy and interchangeability of various clobetasol propionate vehicles in the management of steroid-responsive dermatoses Feldman S R CRD summary This review compared lotion and cream preparations containing clobetasol (...) to have been to compare lotion and cream formulations of clobetasol propionate. Searching MEDLINE and websites of unspecified dermatologic journals were searched from 1975 to November 2004; the search terms were reported. Study selection Study designs of evaluations included in the review All study designs were eligible for inclusion. Specific interventions included in the review It appeared that studies with high-potency (class I) corticosteroid cream and/or lotion treatment arms were eligible

2005 DARE.

4. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis

Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis Medication formulation affects quality of life (...) : a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis Bergstrom K G, Arambula K, Kimball A B Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions

2003 NHS Economic Evaluation Database.